Detalles de la búsqueda
1.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med
; 385(25): 2348-2360, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587382
2.
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.
J Infect Dis
; 222(11): 1837-1842, 2020 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496516
3.
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
J Virol
; 93(21)2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31434737
4.
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
Clin Infect Dis
; 67(11): 1712-1719, 2018 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29590326
5.
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
J Infect Dis
; 215(9): 1376-1385, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28199679
6.
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
J Infect Dis
; 213(4): 541-50, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26475930
7.
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
N Engl J Med
; 369(22): 2083-92, 2013 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24099601
8.
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
J Infect Dis
; 210(1): 99-110, 2014 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24403557
9.
Theoretical model of critical issues in informed consent in HIV vaccine trials.
AIDS Care
; 26(11): 1452-60, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24865892
10.
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
J Infect Dis
; 208(5): 818-29, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23840043
11.
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial.
EBioMedicine
; 100: 104987, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38306894
12.
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.
Lancet HIV
; 11(5): e285-e299, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38692824
13.
Mixed Origins: HIV gp120-Specific Memory Develops from Pre-Existing Memory and Naive B Cells Following Vaccination in Humans.
AIDS Res Hum Retroviruses
; 39(7): 350-366, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36762930
14.
Daily fosfomycin versus levofloxacin for complicated urinary tract infections.
mBio
; 14(5): e0167723, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37698412
15.
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens.
EBioMedicine
; 84: 104271, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179551
16.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090638
17.
Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequences.
J Virol
; 84(11): 5802-14, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20335256
18.
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.
J Virol
; 84(1): 630-8, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19846512
19.
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.
J Infect Dis
; 201(1): 132-41, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19929694
20.
CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques.
Front Immunol
; 12: 757811, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34745131